Brendel Financial Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3	Closed	–	–	109
2021 Q2	$0	Buy	+3	New	–	﹤0.01%	276